PEN 📈 Penumbra - Overview

Penumbra, Inc. operates as a medical device company, focusing on the design, development, manufacturing, and marketing of innovative products for healthcare applications. The company's product portfolio encompasses a range of solutions, including peripheral products such as the Indigo System, which is utilized for power aspiration of thrombus in the body, as well as mechanical thrombectomy systems like Lightning Flash and Lightning Bolt 7. Additionally, Penumbra offers access products, including guide catheters and distal delivery catheters under various brand names, which facilitate minimally invasive procedures.

The company's product lineup also features neuro embolization coiling systems, including the Penumbra Coil 400 and Penumbra SMART COIL, which provide alternatives for the treatment of aneurysms and other complex neurovascular lesions. Furthermore, Penumbra offers peripheral embolization products, such as the Ruby Coil System, consisting of detachable coils for peripheral applications, as well as the Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter designed for high-flow lumens. The POD System, a single device solution, and the Packing Coil, a complementary device for use in other peripheral embolization products, are also part of the company's offerings.

In addition to its medical devices, Penumbra provides an immersive 3D computer-based technology platform under the real immersive system brand, which enhances the visualization and treatment of complex medical conditions. The company also offers neurosurgical tools, such as the Artemis Neuro Evacuation Device, designed for the surgical removal of fluid and tissue from the ventricles and cerebrum. Penumbra's products are sold through a combination of direct sales organizations and distributors, allowing the company to effectively reach its target markets and customers.

As a publicly traded company listed on the New York Stock Exchange (NYSE) under the ticker symbol PEN, Penumbra, Inc. is committed to delivering high-quality medical devices and solutions that address the evolving needs of the healthcare industry. With its headquarters in Alameda, California, and a global presence, the company is well-positioned to drive growth and innovation in the medical device sector. Penumbra's common stock is classified under the GICS Sub Industry of Health Care Equipment, reflecting its focus on developing and marketing medical devices that improve patient outcomes and enhance the quality of care.